Navigating Cannabis Law: Federal vs. State Conflicts

Source: Harter Secrest & Emery LLP, April 1, 2022

For Patients:

Understanding the Clash
This article explores the challenges caused by cannabis remaining illegal under federal law while many states have legalized it for medical or recreational use. The disparity creates confusion for patients, businesses, and financial institutions.

Key Highlights:

  • Federal Illegality: Cannabis is classified as a Schedule I substance under the Controlled Substances Act, deeming it unlawful federally.
  • State Legalization: Despite federal laws, numerous states have legalized cannabis in some form, fostering industry growth.
  • Practical Impact: Patients face uncertainties around access, use, and employer testing policies. Financial institutions often avoid dealing with cannabis businesses, leaving the industry underbanked.

The VitalPoint for Patients:
Understanding this legal dichotomy is critical for patients. It impacts access, affordability, and the ability to use cannabis without fear of legal repercussions or job loss. Being informed ensures better navigation through complex regulations.

For more details, visit https://hselaw.com/news-and-information/in-the-news/a-cannabis-conflict-of-law-federal-vs-state-law/

Cannabis Patient Regulation
VitalPoint Technologies, Inc.

Disclaimer

None of the statements in this announcement or via any web sites linked herein have been evaluated by the FDA. Furthermore, none of the statements in this announcement or any web sites linked herein should be construed as dispensing medical advice or making claims regarding the cure of diseases. You should consult a licensed health care professional before starting any supplement, dietary, or exercise program, especially if you are pregnant or have any pre-existing injuries or medical conditions. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any diseases.

Scroll to Top